Skip to main content
Published locations for TNBC: Atezolizumab plus nab-paclitaxel shows survival benefit in PD-L1-positive patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
TNBC: Atezolizumab plus nab-paclitaxel shows survival benefit in PD-L1-positive patients
User login
Username
Password
Reset your password
/content/tnbc-atezolizumab-plus-nab-paclitaxel-shows-survival-benefit-pd-l1-positive-patients
/hematology-oncology/article/243651/breast-cancer/tnbc-atezolizumab-plus-nab-paclitaxel-shows
/breast-cancer-icymi/article/243651/breast-cancer/tnbc-atezolizumab-plus-nab-paclitaxel-shows